PRESS RELEASE published on 07/27/2023 at 16:35, 2 years 11 months ago Kaufman & Broad SA: AVAILABILITY OF THE 2023 THE HALF YEARLY INTERIM FINANCIAL REPORT
PRESS RELEASE published on 07/27/2023 at 16:35, 2 years 11 months ago Kaufman & Broad SA: MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023
PRESS RELEASE published on 07/13/2023 at 18:05, 3 years ago Kaufman & Broad SA: IMPLEMENTATION OF THE SHARE BUY-BACK PROGRAM
PRESS RELEASE published on 07/13/2023 at 18:05, 3 years ago Kaufman & Broad SA: MISE EN ŒUVRE DU PROGRAMME DE RACHAT D’ACTIONS
PRESS RELEASE published on 07/12/2023 at 18:11, 3 years ago Kaufman & Broad SA: 1ST HALF 2023 RESULTS
PRESS RELEASE published on 07/12/2023 at 18:11, 3 years ago Kaufman & Broad SA: RESULTATS DU 1ER SEMESTRE 2023
PRESS RELEASE published on 07/06/2023 at 16:51, 3 years ago Kaufman & Broad SA: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE DE LA SOCIETE KAUFMAN & BROAD SA
PRESS RELEASE published on 07/06/2023 at 16:51, 3 years ago Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA
PRESS RELEASE published on 05/10/2023 at 17:20, 3 years 2 months ago Kaufman & Broad SA: RESULTAT DES VOTES A L'ASSEMBLÉE GÉNÉRALE MIXTE ORDINAIRE ET EXTRAORDINAIRE DU 4 MAI 2023
PRESS RELEASE published on 05/10/2023 at 17:20, 3 years 2 months ago Kaufman & Broad SA: RESULT OF VOTES OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF MAY 4, 2023
Published on 07/22/2026 at 15:00, 2 hours 41 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 2 hours 41 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 3 hours 6 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 3 hours 11 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 16:49, 52 minutes ago Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
Published on 07/22/2026 at 16:30, 1 hour 11 minutes ago Befar Group Achieves Mass Production of 6N-Grade High-Purity Hydrogen Fluoride
Published on 07/22/2026 at 16:30, 1 hour 11 minutes ago Le groupe Binzhou Chemical a réalisé la production en série d'hydrofluorure à haute pureté de grade 6N, contribuant à l'autonomie et à la maîtrise de la chaîne d'approvisionnement des puces de fabrication avancée en Chine
Published on 07/22/2026 at 15:59, 1 hour 42 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 07/22/2026 at 15:26, 2 hours 15 minutes ago Chiffres d'Affaires du 1er Trimestre de l'Exercice 2026/2027
Published on 07/22/2026 at 08:03, 9 hours 38 minutes ago Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:03, 9 hours 38 minutes ago Mise à disposition du Rapport Financier Semestriel 2026
Published on 07/22/2026 at 08:00, 9 hours 41 minutes ago Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy
Published on 07/22/2026 at 08:00, 9 hours 41 minutes ago Neoen lance la construction du parc éolien de Narrogin en Western Australia après avoir signé un PPA avec Synergy
